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Cluster 1 streptokinases (SK1) from Streptococcus pyogenes (GAS) show substantially higher human
plasminogen (hPg) activation activities and tighter hPg binding afﬁnities than cluster 2b streptokin-
ases (SK2b) in solution. The extent to which the different domains of SK are responsible for these
differences is unknown. We exchanged each of the three known SK domains (a, b, and c) between
SK1 and SK2b and assessed the function of the resulting variants. Our results show that primary
structural differences in the b-domains dictate these functional differences. This ﬁrst report on
the primary structure–functional relationship between naturally occurring SK1 and SK2b sheds
new light on the mechanism of hPg activation by SK, a critical virulence determinant in this species
of human pathogenic bacteria.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Plasminogen (hPg), a soluble plasma 791-residue single-chain
glycoprotein, is the zymogen form of the serine protease, plasmin
(hPm), a major component of the mammalian ﬁbrinolytic system.
In humans, hPg is activated to hPm as a result of cleavage of a sin-
gle peptide bond, Arg561–Val562 in hPg, thus forming the disulﬁde-
linked two-chain, hPm [1]. Mammalian hPg activators, e.g., uroki-
nase-type plasminogen activator (uPA) and tissue-type plasmino-
gen activator (tPA), are themselves serine proteases with
exquisite speciﬁcity for hPg activation. On the other hand, one crit-
ical and highly speciﬁc activator of hPg, viz., streptokinase (SK), se-
creted by several streptococcal strains, including the human
pathogen, Streptococcus pyogenes (GAS), is a single-chain protein
of 414 amino acids [2]. This protein forms a line of communication
between the bacterium and the human host for establishing a pro-
teolytic environment for GAS, a feature that greatly enhances its
invasive properties [3]. One unique feature of SK is that it is not
a protease, and the manner in which it activates hPg through a ser-
ies of protein–protein complexes, has been a subject of detailed
study [4].
Until recently, nearly all mechanistic studies of hPg activation
by SK were performed with SKg, a SK from Streptococcus dysgalac-tiae subsp. equismilis, which has been widely used in humans to
dissolve ﬁbrin-containing thrombi that cause myocardial infarc-
tions [5,6]. The X-ray crystal structure of SKg bound to the catalytic
domain of human plasmin (hPm) shows that SK consists of three
similar ‘‘b-grasp-folding’’ domains (a, b, and c domains), separated
by two ﬂexible loops. These three domains bind to the isolated
hPm catalytic domain and form a ‘‘three-sided crater’’ around the
hPm active site [7].
Numerous studies have been aimed at elucidating the function
of each SK domain in hPg/hPm binding and activation. Various SK
variants, including single and multiple domain constructs and
point mutations [8–19], have been generated to attempt to clarify
the functions of each of the SK domains in hPg binding and activa-
tion. Collectively, these studies generated a complex mixture of
functional effects leading to a variety of different conclusions,
but all of these studies agreed that there is some level of coopera-
tion between the domains in hPg activation.
While many of these investigations relied on mutagenic
changes in one strain of SK, SKg, other opportunities have arisen
from ﬁndings that natural SKs from different GAS strains show
considerable sequence variability, especially in their b-domains
[20,21]. From the diversity of these primary structures, SKs from
GAS were classiﬁed into two clusters, cluster 1 (SK1) and cluster
2 (SK2). Based on sequence analyses, cluster 2 was further subdi-
vided into cluster 2a (SK2a) and 2b (SK2b) [20]. Recent data ob-
tained on SK1 and SK2b demonstrated that their properties
toward hPg binding and activation were very different [3,21], thus
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examined. In this regard, exchange of a partial b domain (residues
124–238) between SKs from GAS strains NZ131 and SF13013 has
been performed, but did not uncover any effects on hPg activation
kinetics [22]. In retrospect, this result would be expected since the
two SKs, themselves, show similar hPg activation functions, de-
spite the fact that the two regions exchanged share less than 50%
identity.
This variety of available natural SK variants offers rational
mutagenesis strategies to study the structure–function relation-
ships of SK. Exchange of domains between cluster 1 and cluster
2b SKs have been performed, and the resulting hPg binding and
activation activity changes are revealed in the current study.
2. Materials and methods
2.1. cDNAs and proteins
DNA sequences of cluster 1 sk (sk1) clones, skNS210, skNS53,
skNS931, skNZ131, and cluster 2b sk (sk2b) clones, skAP53, skNS223,
skNS455 and skNS88.2, have been described in a previous study
[21]. Among this group, skNS931 and skNS88.2 were employed as pro-
totypical wild-type (WT) sk1 and sk2b, respectively. These genes
were assembled into plasmid pET42a (EMD4 Biosciences, Ger-
many) [21] for gene mutagenesis and protein expression.
Human full-length Glu1-plasminogen (hPg), and its latent hPm
active-site mutant, hPg [S741A], were expressed in Drosophila
Schneider S2 cells and puriﬁed as described [21,23].
2.2. Construction, expression and puriﬁcation of SK mutants
PCR-mediated overlap-extension was used to construct SK mu-
tant expression plasmids [24]. The primers used are listed in Sup-
plementary Table 1 and the strategy of their use to construct the
variants is shown in Supplementary Table 2. The resulting con-
structions contained the coding sequences for 414 amino acid res-
idues of rSK variants, placed between restriction sites PshAI and
BamHI of pET42a (EMD4Biosciences, Germany). For expression,
Escherichia coli BL21(DE3) cells (New England Biolabs, USA) were
transformed with the pET42a constructs. Importantly, all rSKs gen-
erated were designed to contain their natural amino-terminal ami-
no acid [25].
The SK variant proteins were expressed and puriﬁed as de-
scribed [21]. The purity of all rSK mutants was assessed with 12%
SDS–PAGE. Protein concentrations were measured at A280nm using
the calculated (Protein Calculator, version 3.3) extinction coefﬁ-
cients (M1 cm1): rSKM1, 35130; rSKM2, 31290; rSKM3, 33850;
rSKM4, 32570; rSKM5, 32570; rSKM6, 33850.
2.3. Circular dichroism (CD) measurements
CD spectra were collected between 190–240 nm using an AVIV
202SF spectrometer (Lakewood, NJ). Spectral scans were obtained
at 25 C at 0.2 nm intervals at a rate of 60 nm/min, in a 0.1 cm
quartz cuvette. Three runs were averaged for each sample. A buffer
reference scan was subtracted from the sample scans. The mean
residue elipticities (MRE) were calculated using the equation,
MRE = (h MRW)/(1  c), where h is the CD signal in millidegrees,
MRW is the mean residue weight in g/mol, l is the path length in
millimeters and c is the protein concentration in mg/ml.
2.4. Activation of Glu1-hPg
HPg activation rates were monitored in 96-well microtiter
plates in Cl buffer to maintain the closed (tight) conformation
of hPg [26,27]. The activation of hPg was accelerated by theaddition of catalytic levels of rSK as detailed earlier [21]. The
amidolytic activity of the generated plasmin (hPm) was continu-
ously monitored by the absorbance (A) at 405 nm from release
by plasminolysis of pnitroanilide (pNA) from the chromogenic
substrate, S2251 (H-D-Val-Leu-Lys-pNA; Chromogenix, Italy).
Because, under these conditions, the A405nm reﬂects hPm activity
from continually increasing [hPm], for more quantitative estimates
the A405nm was also plotted against t2 [28]. The initial velocities
were then calculated from the slopes of the linear regions of
these plots. All data transformations and linear regressions were
performed using GraphPad Prism 5.
2.5. Surface plasmon resonance (SPR)
Kd values of hPg binding to SK were measured by SPR with a
BIAcore X100 (GE Healthcare) from association (kon) and dissocia-
tion (koff) rates. A hPg mutant, rhPg[S741A], in which the latent ac-
tive-site, Ser741, was replaced with Ala, was used to avoid hPm
production during the binding process. Our procedural details have
been described [21].
3. Results and discussion
3.1. Conservation and diversity between SK1 and SK2b
Previous studies have revealed that SK1 and SK2b showed sig-
niﬁcant differences in binding to, and activation of, hPg [3,21,29].
SK1 displays a >10-fold tighter binding afﬁnity, and a correspond-
ingly higher activation activity toward hPg than SK2b [21]. To ex-
plore the primary structural features of SK that are responsible for
these differences, the amino acid sequences of four SK1s and four
SK2bs from various GAS strains [21] were compared (Fig. 1A).
The a- and c-domains showed higher conservation (77% and 84%
identity, respectively) than the b-domains (55% identity) among
all these SKs (asterisked, Fig. 1A). This is consistent with the ﬁnding
that the SK b-domain displays the highest level of sequence heter-
ogeneity [20]. When those diverse residues (unasterisked, Fig. 1A)
were investigated, a number of residues (boxed in Fig. 1A) were
found to be conserved in the SK1 cluster, but were different be-
tween the SK1 and SK2b clusters.
Although a larger proportion (53%) of these cluster-conserved
residues appeared in the b-domain, they were also found in the
a- and c-domains (30% and 17%, respectively). This indicates that
all three domains are potential determinants for the functional dif-
ferences between SK1 and SK2b. In addition, from the results ob-
tained with SKg, all three domains have been suggested to play
roles in both hPg binding and activation [12,16,18,30,31]. However,
information provided to this time does not yield sufﬁcient infor-
mation to conﬁrm which domain or domains plays a determinate
role in hPg activation.
3.2. Expression, puriﬁcation, and secondary structural analysis of SK
mutants
SK contains three independent functional domains, separated
by ﬂexible loops, with no direct interaction between domains
[30]. Thus, it is plausible that swapping one domain between two
SKs will not affect the functions of the other two, and/or that the
new domain introduced will display functions attributed to its par-
ent SK.
To further determine which domain or domains plays the deter-
minate role in the large functional differences between SK1 and
SK2b, one SK from each cluster was selected for domain-swapping
investigations, viz., SKs from GAS strains NS931 (SK1NS931) and
NS88.2 (SK2bNS88.2), respectively. Six mutants, SKM1 through
SKM6, were then constructed by exchanging each of the three
Fig. 1. Structures of the proteins employed. (A). Sequence alignments of SK and SK2b from various GAS strains. Shown are amino-acid sequences of four SK1s (SKNS210, SKNS53,
SKNS931, SKNZ131) and four SK2bs (SKAP53, SKNS223, SKNS455 and SKNS88.2) [21,32]. Strictly conserved residues in all SK1s and SK2bs are indicated with asterisks. The residues that
are strictly conserved in one cluster, and different between clusters, are boxed (clear boxed for SK1, black boxed for SK2b). The sequence alignments were performed with
ClustalX [33]. (B). Diagrams of the a, b, and c domain-exchanged SK mutants from SK1 (NS931) and SK2b (NS88.2) used in this study. Domains were assigned according to the
crystal structure of SKg [30].
Fig. 2. SDS–polyacrylamide gels showing the rSK mutants puriﬁed in this study.
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in the scheme of Fig. 1B. The mutants were expressed in E. coli
BL21(DE3) and puriﬁed as described [21]. Final yields were 8–
12 mg protein/l culture, and SDS–PAGE (Fig. 2) showed that these
mutants display >95% purity and appear in the expected calculated
size range (44–49 kDa).
Far-UV circular dichroism (CD) spectroscopy was employed to
compare the secondary structures of these rSK mutants with WT-
rSK1NS931 and WT-rSK2bNS88.2. As shown (Fig. 3), despite the do-
main diversities, the puriﬁed rSK domain-exchanged mutants
showed very similar CD spectra to those of the WT-rSKs through-
out the wavelength range of 192–240 nm. The output spectra ob-
tained were typical of those expected for a combination of a
helical (minima at 208 and 222 nm, maxima at 190 nm) and b-
sheet (minima at 218 nm, maxima at 196 nm), indicative of the
known structure of SK [30]. When the CD spectra of all WT and
mutant SK’s were analyzed with an online CD structural algorithm
(http://geneura.ugr.es/cgi-bin/somcd/som.cgi?start=1), the a-heli-
cal content ranged from 12–20%, the b-sheets from 35–40%, the
b-turn content from 9–12%, and random structures from 29–38%;all within experimental uncertainty of the method. Thus, these
high similarities in the rSK mutants with WT-rSKs indicates that
swapping of domains does not substantially affect the gross struc-
tures of SKs.
Fig. 3. Far-UV CD spectra of the puriﬁed domain-exchanged SK mutants. Each curve
is an average of 3 scans/protein (2 lM) in 10 mM sodium phosphate, pH 7.4, 25 C.
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differences between SK1 and SK2b
SK1 activates hPg at a much higher rate than that of SK2b [3,20].
To study whether such an important property resides within spe-
ciﬁc domains of SK1, the corresponding hPg-activation activities
of the above-puriﬁed domain-exchanged mutants were measured
and compared to those of the WT-SKs. As shown (Fig. 4A and B),
when the SK1NS931 a-domain (a1) was replaced by the a-domain
from SK2bNS88.2 (a2b), the hPg activation rate in solution by the
resulting rSKM1 (a2bb1c1), of 0.43 mA405nm/min2, was somewhat
attenuated from that of WT-SK1NS931 (a1b1c1), which was deter-
mined to be 1.08 mA405nm/min2. However, the increase in hPgFig. 4. Activation of rGlu1-hPg by puriﬁed domain-exchanged SK mutants. (A). The
rate of development of amidolytic activity monitored continuously by the absor-
bance at 405 nm at 37 C using the chromogenic hPm substrate, S2251 (H-D-Val-
Leu-Lys-pNA2HCl). The control without rSK (dashed line) was performed under the
same conditions. The inset shows the transformed plot of Absorbance at 405 nm vs.
t2. (B). The initial velocities of hPm appearance for each rSK variant as calculated by
linear regression from the linear regions of plots A405 nm vs. t2.activation rate by rSKM1 is still much faster, by 13-fold, than that
of rSK2bNS88.2 (a2bb2bc2b) and rSKM2 (a1b2bc2b).
Similarly, exchange of the c1 domain for c2b in rSK2bNS88.2, pro-
viding mutant rSKM6 (a2bb2bc1), did not enhance the very low hPg
activation activity of rSK2bNS88.2, and exchange of c2b with c1 in
rSKNS931, yielding rSKM5 (a1b1c2b), attenuated the activation rate
by approximately one-half of that of WT-rSK1NS931 (Fig. 4A and
B). These slightly diminished activation rates suggest minor roles
for the a- and c-domains in enhancing activation of hPg by SK1
in solution, but the overall similar activation rates of the mutants
as those of their parental WT-SKs indicated that neither the a-do-
main nor the c-domain is a determinant of the activity differences
between SK1 and SK2b.
3.4. The b-domain plays a pivotal role in the hPg activation differences
between SK1 and SK2b
More dramatic effects are noted in SK activation of hPg when con-
sidering the SK b-domains. Introduction of b2b in place of b1 in
rSK1NS931, yielding variant rSKM3 (a1b2bc1), resulted in a 35-fold
reduction of activity from WT-rSK1NS931, which was actually equal
to that of rSK2bNS88.2 (Fig. 4A and B), while the replacement of b2b
by b1, providing variant rSKM4 (a2bb1c2b), enhanced the hPg activation
activity in solution by 12-fold (Fig. 4A and B). Clearly, the b-domain
plays an important functional role in the ability of SK1 to activate hPg.
Thus, whereas the b1 region is by-far the most important do-
main for the high activity of SK1 compared to SK2b, the a1 and
c1 domains assist, probably in a synergistic fashion, in achieving
the high activation rates seen in WT-SK1, compared to WT-SK2b,
as can be seen in the variants with the a1 or c1 domains replaced
by a2b or c2b, in which the activation rates of SK1 decreased 55%
in rSKM1 and 42% in rSKM5.
3.5. b-Domain exchanges lead to large changes in binding afﬁnities of
SK to hPg
Another signiﬁcant functional difference between SK1 and SK2b
is that SK1 shows a >10-fold higher afﬁnity to hPg than SK2b, as
typiﬁed by WT-rSK1NS931 and WT-rSK2bNS88.2 (Table 1). This over-
all ﬁnding is in-keeping with the more rapid activation of hPg in
solution by SK1 [3,21]. To study whether individual domains of
SK1 and SK2b independently determine the afﬁnities of SK1 and
SK2b to hPg, SPR was used to investigate the binding energies of
the SK mutants to hPg. Some example sensorgrams are shown in
Fig. 5 and the Kd values are listed in Table 1.
Compared to WT-rSK1NS931 (a1b1c1), the introduction of a2b
into SK1 in place of a1, in the variant rSKM1 (a2bb1c1), results in a
very small effect on the Kd (Table 1), as is the case when the c1 do-
main is replaced by c2b in variant rSKM5 (a1b1c2b). In neither case
was the Kd increased by >twofold. These binding data, similar to
the results of the activation kinetics, suggest that the a1 and c1 do-
mains do not contribute substantially to the different binding
afﬁnities SK1 and SK2b to hPg. However, introduction of b2b forTable 1
Kd values of rSK variants to hPg [S741A].
Protein Domains Kd (nM)
WT-rSKNS931a a1b1c1 12
WT-rSKNS88.2a a2bb2bc2b 202
rSKM1 a2bb1c1 24
rSKM2 a1b2bc2b 74
rSKM3 a1b2bc1 121
rSKM4 a2bb1c2b 11
rSKM5 a1b1c2b 19
rSKM6 a2bb2bc1 253
a Values taken from [21].
Fig. 5. Binding of rSKs to rGlu1-hPg[S741A]. SPR sensorgrams for rSKM1–rSKM6 are illustrated. The curves in each panel represent the binding of the indicated concentrations of
the rSKs to rGlu1-hPg[S741A] immobilized on a CM5 chip. The sensorgrams shown were generated by subtraction of the nonspeciﬁc refractive index component from the total
binding. The CM5 chips were coupled with 1000 RU of rGlu1-hPg[S741A]. To calculate the Kd for each of these SK variants, the protein concentration ranges were: rSKM1, 5–
250 nM; rSKM2 and rSKM3, 10–500 nM; rSKM4, 1–50 nM; rSKM5, 2.5–100 nM; and rSKM6, 50–1500 nM. Sensorgrams for the WT-rSK1NS931 and WT-rSK2bNS88.2 are shown in
Ref. [21].
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compared to WT-rSK1NS931, brought the binding properties of
rSKM3 closer to WT-rSK2bNS88.2 as a result of this single b-domain
exchange. These data demonstrate that the tighter binding afﬁnity
and corresponding higher activation rates of WT-rSK1NS931, as
compared to WT-rSK2bNS88.2, is primarily determined by b-domain
differences.
Other domain exchanges between SK1NS931 and SK2bNS88.2 (Ta-
ble 1) allow similar conclusions to be reached. Speciﬁcally, replace-
ment of the a2b and c2b domains of rSK2bNS88.2 (a2bb2bc2b) with a1
and c1 from rSK1NS931, providing variants rSKM2 (a1b2bc2b) and
rSKM6 (a2bb2bc1), did lead to an 3-fold enhancement in binding
afﬁnity in the case of rSKM2, compared to WT-rSK2bNS88.2, but still
ﬁvefold weaker than WT-rSK1NS931. In the case of rSKM6 (Table 1),
the c1 domain substitution did not affect its binding energy to
rhPg[S741A], when compared to rSKNS88.2. However, exchange of
the b1-domain for b2b, yielding variant rSKM4 (a1b2bc1), showed
an 18-fold higher afﬁnity to rhPg[S741A] than WT-rSK2bNS88.2, a va-
lue nearly the same as WT-rSK1NS931. On the whole, the changes of
afﬁnities to hPg are consistent with the changes of hPg activation
activities and demonstrate the critical role of the b-domain of SK,
with synergy provided by the a-domain, in dictating the nature
of its hPg activation activity speciﬁcity.
3.6. Conclusion and future prospects
The mutational and functional analyses provided in this study
have revealed that the primary structural differences in the
b-domain of SK is a major determinant of the important functionaldifferences of SK1 and SK2b toward hPg activation. This largely
narrows the range for other mutations to generate to assess the
diverse functional properties of SKs produced by GAS strains with
distinct tissue tropism and virulence. Since host hPm is a critical
virulence determinant in this human pathogenic bacterium, under-
standing the nature of its activation in GAS is a very important goal
in developing methods to attenuate the effects of GAS in humans.
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